Please note: AABB reserves the right to make updates to this program.
Thursday, March 26, 2020
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 20EL-519 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Patient Blood Management
Intended Audience: Hospitals, Hospital Blood Banks, Medical Directors, Nurses, Physicians, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officer
Teaching Level: Basic to Intermediate
Director/Moderator: Addisalem Taye Makuria, MD, Medical Officer, Devices Review Branch, Division of Blood Components and Devices, Office of Blood Research and Review, Center for Biologics Evaluation & Research, U.S. Food and Drug Administration
Speaker: Meghan Delaney, DO, MPH, Chief, Pathology & Laboratory Medicine Division, Medical Director, Transfusion Medicine, Children’s National Medical Center; Associate Professor, Pathology & Pediatrics, The George Washington University, Washington DC
After participating in this educational activity, participants should be able to:
- Describe the evidence-based medicine that guides the transfusion of pediatric patients.
- Discuss the development of clinical practice guidelines to support pediatric transfusion programs.
- Discuss future challenges and opportunities of pediatric PBM programs.
Patient blood management is a standard of care that focuses on measures to reduce or avoid the need for a blood transfusion. In this eCast, the evidence-based medicine approaches that guide pediatric transfusion medicine and how they apply to patient blood management will be discussed. The strategies that are common to all patient blood management programs as well as those more unique to pediatrics will be reviewed.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Continuing Education Credit
AABB estimates both the live and on-demand version of this eCast each to be eligible for 1 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) will be determined by the program duration. For more information on each credit type please visit our
Continuing Education Credits webpage.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.
Dr. Meghan Delaney received a Doctor of Medicine degree from the University of New England College of Osteopathic Medicine in Biddeford, Maine, and a Master of Public Health degree from the University of Washington School of Public Health in Seattle, Washington. Dr Delaney is the Chief of Pathology & Laboratory Medicine at Children’s National Health System based in Washington, DC. The Division performs vital diagnostic testing and interpretation services for all divisions at Children’s National Health System, including Children’s regional outpatient centers, and mobile health units in the greater Washington, DC, area. A Diplomate of the American Board of Pathology with certification in transfusion medicine/blood banking and clinical pathology, Dr. Delaney is an active member of several professional societies. She serves as Chair of the AABB Transfusion Medicine Subsection Pediatric Subcommittee and as Chair of the American Society of Apheresis Applications Committee Pediatric Subcommittee. She is a Scientific Member of the BEST Collaborative and is a member of the American Board of Pathology Test Development and Advisory Committee. Dr. Delaney is an Associate Editor for the journal Transfusion Medicine and a member of the editorial board of Transfusion. Dr Delaney’s clinical and scholarly focus is on transfusion medicine, pediatric transfusion medicine and testing for blood that is difficult to match. She has over 70 scientific publications, over 15 book chapters, numerous review articles and invited lectures nationally and internationally. In global health, she focuses on medical education and sustainable technology development in developing nations.